DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,349,078 | -46.6% | 119,918 | -45.3% | 0.21% | -50.0% |
| Q1 2023 | $2,526,520 | +2949.3% | 219,316 | +2967.8% | 0.42% | +2244.4% |
| Q4 2022 | $82,857 | -93.4% | 7,149 | -93.2% | 0.02% | -87.0% |
| Q4 2021 | $1,251,000 | -65.8% | 105,204 | -53.3% | 0.14% | -55.0% |
| Q3 2021 | $3,655,000 | -53.0% | 225,083 | -39.1% | 0.31% | -41.6% |
| Q2 2021 | $7,779,000 | +11.3% | 369,714 | -17.9% | 0.53% | -1.9% |
| Q1 2021 | $6,989,000 | +232.8% | 450,064 | +350.1% | 0.54% | +188.2% |
| Q4 2020 | $2,100,000 | +48.6% | 100,000 | +42.9% | 0.19% | +33.8% |
| Q3 2020 | $1,413,000 | – | 70,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |